Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Colitis, Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 12/13/2018 |
| Start Date: | December 12, 2012 |
| End Date: | July 1, 2019 |
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
The purpose of this study is to determine whether RPC1063 is effective in the treatment of
ulcerative colitis (UC).
ulcerative colitis (UC).
Inclusion Criteria:
- Ulcerative colitis (UC) confirmed on endoscopy
- Moderately to severely active UC (Mayo score 6-12)
Exclusion Criteria:
- Current use of anti-TNF agents
We found this trial at
6
sites
Anaheim Clinical Trials, LLC Anaheim Clinical Trials (ACT) is a research center of excellence for...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials